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Summary 
 
Lipid A anchors the lipopolysaccharide (LPS) to the outer membrane and is usually 
composed of a hexa-acylated diglucosamine backbone. Burkholderia cenocepacia, an 
opportunistic pathogen, produces a mixture of tetra- and penta-acylated lipid A. 
"Late" acyltransferases add secondary acyl chains to lipid A after the incorporation of 
four primary acyl chains to the diglucosamine backbone. Here, we report that B. 
cenocepacia has only one late acyltransferase, LpxL (BCAL0508), which adds a 
myristoyl chain to the 2' position of lipid A resulting in penta-acylated lipid A. We also 
identified PagL (BCAL0788), which acts as an outer membrane lipase by removing the 
primary β-hydroxymyristate (3-OH-C14:0) chain at the 3 position, leading to tetra-
acylated lipid A. Unlike PagL, LpxL depletion caused reduced cell growth and defects 
in cell morphology, both of which were suppressed by overexpressing the LPS 
flippase MsbA (BCAL2408), suggesting that lipid A molecules lacking the fifth acyl 
chain contributed by LpxL are not good substrates for the flippase. We also show that 
intracellular B. cenocepacia within macrophages produced more penta-acylated lipid 
A, suggesting lipid A penta-acylation in B. cenocepacia is required not only for 
bacterial growth and morphology but also for adaptation to intracellular lifestyle.  
	 3	
Introduction 
 
Lipopolysaccharide (LPS), the chief constituent of the surface-exposed leaflet of the Gram-
negative bacterial outer membrane, consists of discrete structural regions including lipid A, 
core oligosaccharide (core), and in many bacteria the repeating O-antigen units (Nikaido, 
2003). The lipid A is a glycolipid that anchors LPS to the outer membrane; its structure and 
that of the inner portion of the core are highly conserved (Raetz et al., 2007, Whitfield and 
Trent, 2014). Lipid A-core biogenesis starts at the cytoplasmic face of the inner membrane 
and then the molecule is transported across the membrane to the periplasmic side. LPS 
export to the outer membrane's external leaflet occurs through LPS transport proteins (Lpt), 
which form a multi-protein complex that links the inner and outer membranes and consumes 
energy from ATP hydrolysis (Okuda et al., 2016).  
 LPS, particularly lipid A, is one of the most characteristic microorganism-associated 
molecular patterns activating the host innate immune system. Lipid A is detected by the Toll-
like receptor 4 (TLR4) in complex with the myeloid differentiation factor 2 (MD2), both of 
which are on the cell surface of immune cells like macrophages and monocytes (Beutler, 
2002, Di Lorenzo et al., 2015, Park and Lee, 2013). Binding of lipid A to TLR4–MD2 triggers 
the release of pro-inflammatory cytokines resulting in an inflammatory response that 
eventually clears the infection. This inflammatory response can be highly robust and its 
deregulation leads to potentially fatal consequences especially in cases of sepsis (Bryant et 
al., 2010).  
 Bacteria modify and remodel the basic lipid A backbone in response to environmental 
cues. These modifications become critical for bacteria to infect and survive in the host 
(Raetz et al., 2007). For example, Escherichia coli lipid A, with six acyl chains and 2 
phosphate groups is the strongest known TLR4 agonist; however, the tetra-acylated form is 
an antagonist that blocks the TLR4 signalling pathway (Needham and Trent, 2013). Other 
modifications of the lipid A can either render LPS unrecognizable as a microorganism-
associated molecular pattern or impart bacterial resistance to immune effectors, such as 
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antimicrobial peptides and antibiotics. This can be accomplished through addition of 
positively charged chemical groups to the lipid A phosphates, such as phosphoethanolamine 
(Lee et al., 2004, Kim et al., 2006), 4-L-amino-4-deoxyarabinose (L-Ara4N) (Trent et al., 
2001), galactosamine (Wang et al., 2009) and glucosamine (Marr et al., 2008). These 
substitutions reduce the overall negative charge of the bacterial surface promoting 
resistance to antimicrobial peptides such as polymyxin B. The degree of lipid A acylation and 
phosphorylation is also important for lipid A recognition by TLR4-MD2 complex and for 
membrane packing, which maintains the stability of the outer membrane and reduces the 
diffusion of hydrophobic molecules. Therefore, changes in the number and properties of acyl 
chains play an important role in lipid A adaptive modifications (Needham and Trent, 2013). 
 Gram-negative pathogens have evolved several adaptive LPS modification strategies 
(Needham and Trent, 2013, Raetz et al., 2007). Lipid A remodelling can occur either during 
or after trafficking to the cell surface. In general, the modification enzymes are not essential 
for bacterial viability in vitro but they can be critical during infection (Needham and Trent, 
2013). 
 Burkholderia cenocepacia is an opportunistic Gram-negative pathogen that has become 
a health threat to patients with cystic fibrosis (Mahenthiralingam et al., 2008, Vandamme and 
Dawyndt, 2011). The B. cenocepacia lipid A consists of two linked glucosamine residues 
that contain phosphodiester-linked L-Ara4N residues (Silipo et al., 2005). Unlike most 
bacteria, the L-Ara4N residues are essential for B. cenocepacia viability and LPS export to 
the outer membrane (Hamad et al., 2012, Ortega et al., 2007). A disaccharide made of 3-
deoxy-D-manno-oct-2-ulosonic acid (Kdo) and D-glycero-D-talo-oct-2-ulosonic acid (Ko) is 
attached to the B. cenocepacia lipid A, instead of the prototypical Kdo-Kdo disaccharide in 
other bacteria (Silipo et al., 2005). The Ko residue is also glycosylated by L-Ara4N (Silipo et 
al., 2005, De Soyza et al., 2008). The rest of the core is attached to the Kdo residue of the 
lipid A-Kdo-Ko-L-Ara4N molecule. Some B. cenocepacia isolates also contain an O-antigen 
polysaccharide ligated to core and composed of a repeating trisaccharide unit made of two 
residues of N-acetyl galactosamine and one rhamnose residue (Ortega et al., 2005, Ortega 
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et al., 2009).  
 Classical lipid A synthesis requires a nine-step enzymatic machinery known as the Raetz 
pathway (Whitfield and Trent, 2014). The B. cenocepacia genome contains homologs of 
genes encoding eight of the nine canonical enzymes required for the lipid A biosynthesis in 
E. coli (Fig. 1). The Raetz pathway starts by the acylation of the sugar nucleotide; uridine 
diphosphate N-acetylglucosamine (UDP-GlcNAc) by LpxA (BCAL2079) (Anderson et al., 
1985, Anderson and Raetz, 1987). This is followed by five enzymatic steps catalysed by 
LpxC (BCAL3455), LpxD (BCAL2081), LpxH (BCAL2154), LpxB (BCAL2078), LpxK 
(BCAL2759) to produce the lipid IVA molecule (Fig. 1A) (Jackman et al., 1999, Kelly et al., 
1993, Babinski et al., 2002a, Babinski et al., 2002b, Crowell et al., 1986, Garrett et al., 
1997). Kdo-Kdo residues are then incorporated to lipid IVA by WaaA (BCAL3310), which 
uses cytidine monophosphate (CMP)-Kdo as the donor substrate (Fig. 1B) (Clementz and 
Raetz, 1991). In Burkholderia, the distal Kdo residue is converted to Ko by a dioxygenase 
(Chung and Raetz, 2011, Chung et al., 2014) (KdoO; BCAL3311; Hamad and Valvano, 
unpublished; Fig. 1B). In E. coli, addition of secondary acyl chains takes place after the Kdo 
addition (Reynolds and Raetz, 2009) and these steps are performed by two membrane-
bound "late" acyltransferases, LpxL and LpxM. LpxL transfers a lauroyl (C12:0) group to the 
2' position, while LpxM adds a myristoyl (C14:0) group to the 3' position (Clementz et al., 
1996, Clementz et al., 1997). B. cenocepacia has only one extra C14:0 acyl chain added to 
the 2' position, resulting in penta-acylated lipid A (Fig. 1B) (Silipo et al., 2005).  
 After completion of the incorporation of acyl chains, the lipid A-core moiety is flipped 
across the inner membrane by the LPS flippase (MsbA), an ABC transporter, and the O-
polysaccharide formed by an independent pathway is ligated to a terminal core residue 
(Doerrler et al., 2001, Polissi and Georgopoulos, 1996). MsbA is specific for the degree of 
lipid A acylation, thus ensuring that only lipid A species with the appropriate number of acyl 
chains are translocated (Doerrler and Raetz, 2002). LPS is an important virulence factor in 
B. cenocepacia (Di Lorenzo et al., 2015, Khodai-Kalaki et al., 2015, Kotrange et al., 2011, 
Ortega et al., 2009). However, the contribution of the lipid A biosynthetic machinery and 
	 6	
modifications to the pathogenicity and robustness of the bacterium has not been 
systematically investigated (Maldonado et al., 2016). Unlike E. coli and Salmonella enterica, 
lipid A from B. cenocepacia and other Burkholderia species consists of a mixture of tetra and 
penta-acylated species containing one secondary acyl chain (Fig. 1B) (Silipo et al., 2005, 
Silipo et al., 2007). The molecular basis for this distribution of acyl chains is unknown. In this 
study, we established the presence of only one "late" acyltransferase, LpxLBc, which is 
responsible for the addition of the fifth acyl chain to Burkholderia lipid A at the 2' position. 
We also identified the B. cenocepacia PagL lipase that catalyses the 3-O-deacylation at 
position 3, resulting in tetra-acylated lipid A. Further, we show that LpxLBc is required for 
normal growth and cell morphology of B. cenocepacia, which in the absence of LpxLBc 
expression could be regained by overexpressing the MsbA LPS flippase. We also found that 
B. cenocepacia has higher preference towards formation of penta-acylated lipid A in infected 
macrophages, suggesting that penta-acylation of lipid A is important for B. cenocepacia 
adaptation to the intracellular lifestyle. 
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Results 
 
LpxLBc is required for normal growth and cell morphology of B. cenocepacia 
We searched the B. cenocepacia genome for LpxM and LpxL acyltransferase orthologues 
that add secondary acyl chains to the lipid A-Kdo-Ko. BCAL0508 was the only gene 
identified in B. cenocepacia encoding a predicted "late" lipid A acyltransferase. BCAL0508 
had 30% amino acid identity to E. coli LpxM and 34% identity to LpxL. Because the extra 
acyl chain is incorporated at the 2' position of the lipid A (Fig. 1B), which is the location of 
the acyl chain added to the lipid A by the LpxL orthologues in E. coli and S. enterica, we 
renamed BCAL0508 as LpxLBc. Repeated attempts to delete the lpxLBc gene from strain 
K56-2 using the targeted, unmarked deletion method (Flannagan et al., 2008, Aubert et al., 
2014) consistently failed, suggesting this gene could be required for B. cenocepacia viability. 
We constructed a conditional mutant by placing lpxLBc under the control of a rhamnose-
inducible promoter (Cardona et al., 2006). The resulting strain, K56-2(Prha::lpxLBc) (YFM51 in 
Table 1), had reduced growth under the non-permissive condition (0.2% glucose; Fig. 2A). 
This was confirmed by a rhamnose depletion assay in minimal medium monitoring growth 
under permissive and non-permissive conditions for up to 20 h. K56-2(Prha::lpxLBc) grew 
poorly in glucose showing some growth recovery at later time points (Fig. 2B), suggesting 
that LpxL depletion affects growth rate. Delayed growth recovery under the non-permissive 
condition could be due to incomplete halt of lpxLBc gene transcription. Individual bacterial 
cells were examined by phase contrast microscopy, differential interference contrast (DIC) 
microscopy, and transmission electron microscopy. In the presence of rhamnose, K56-
2(Prha::lpxLBc) cells formed short rods at all time points (Fig 2C). In contrast, at late time 
points virtually all K56-2(Prha::lpxLBc) cells from cultures in 0.2% glucose displayed elongated 
morphology forming isolated diplobacilli and also multicellular chains, indicative of cell 
division defects (Fig. 2C, arrows). Fluorescence staining with syto-9, a DNA intercalating 
dye, confirmed that cells contained 2 nucleoids and also some cells showed deformed 
nucleoids (Fig. 2C, arrowheads). Ultrastructural analysis of rhamnose-depleted cultures by 
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transmission electron microscopy revealed incomplete cell divisions, accumulation of 
intramembranous structures, and the presence of empty sacculi (Fig. 3). These 
morphological defects resemble those observed when LPS export to the outer membrane is 
halted (Wu et al., 2006), as we have previously demonstrated in conditional mutants 
defective in L-Ara4N synthesis (Ortega et al., 2007), which have an LPS export defect 
(Hamad et al., 2012). Together, our results support the notion that LpxLBc is required for the 
normal growth and cell morphology of B. cenocepacia. 
 
Conditional suppression of LpxLBc expression leads to a mixture of tri- and tetra-acylated 
lipid A 
Lipid A analysis was carried out on LpxLBc-depleted cultures in K56-2(Prha::lpxLBc) using 
negative ion matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass 
spectrometry. The B. cenocepacia lipid A exhibited a complex fragmentation pattern of 
molecular ion peaks representing tetra and penta-acylated species (see all the assignments 
in Table 2), as previously described (Sturiale et al., 2011). Also, the fragmentation pattern 
was characteristic for the cleavage of the labile bond between Kdo and lipid A (Sturiale et 
al., 2005). Under the permissive condition (0.2% rhamnose), the MALDI-TOF spectrum of 
lipid A obtained from K56-2(Prha::lpxLBc) (Fig. 4A) was identical to that of the parental K56-2 
strain (Fig. 4C) and the previously characterized spectrum of the K56-2 wabR mutant 
(Sturiale et al., 2011, Ortega et al., 2009). Therefore, neither the presence of rhamnose in 
the growth medium nor the insertion of the rhamnose inducible promoter in the bacterial 
genome had any detectable effect on the lipid A profiles. In all cases, the MALDI-TOF 
spectrum contains a characteristic ion peak at m/z 1444.7 corresponding to tetra-acylated, 
bisphosphorylated glucosamine disaccharide (Fig. 4A, left spectrum, and Table 2) (Hamad 
et al., 2012, Sturiale et al., 2011). This ion represents a lipid A molecule containing two 
C16:0(3-OH) chains, one C14:0(3-OH) and one secondary C14:0 chain (Fig. 4B, left, and 
Table 2). This lipid A molecule lacks the primary β-hydroxymyristate (3-OH-C14:0) chain at 
the 3 position (see below). There was also a peak at m/z 1576.8 representing the addition of 
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L-Ara4N (∆m/z = +131 to the peak at m/z 1444.7). The ion peaks at m/z 1364.7 and m/z 
1495.9 correspond to mono-phosphorylated versions (∆m/z = -80 to 1444.7 and 1576.8 ion 
peaks, respectively; Table 2). Peaks at m/z 1671 and 1803.1 were attributed to penta-
acylated, bisphosphorylated lipid A species having an additional myristoyl chain [14:0(3-OH)] 
(∆m/z = +226 to the peaks at m/z 1444.7 and 1576.8, respectively; Table 2). The peak at 
m/z 1707.9 represents a tetra-acylated, bisphosphorylated lipid A species with 2 L-Ara4N 
residues (Fig. 4A, and Table 2). 
 In contrast, under the non-permissive condition (0.2% glucose), each of the former peaks 
appeared, but with ∆m/z= -210 that corresponds to the loss of the secondary C14:0 chain 
attached to the C16:0(3-OH) chain at the 2' position (Fig. 4A, right spectrum, 4B). Therefore, 
we conclude that lipid A produced under the non-permissive condition consists of a mixture 
of tri and tetra-acylated lipid A species. Indeed, the ion peak at m/z 1234.6 corresponds to a 
tri-acylated bisphosphorylated diglucosamine and that at m/z 1366.7 corresponds to tri-
acylated bisphosphorylated diglucosamine with an extra L-Ara4N (Table 2). The ion peaks at 
m/z 1154.6 and 1285.7 denote the mono-phosphorylated versions of the previous peaks. 
The two peaks at m/z 1460.9 and 1593.1 correspond to the tetra-acylated derivatives 
represented by the peaks at m/z 1234.5 and 1366.7, respectively, which have an extra 
C14:0(3-OH) acyl chain (∆m/z = +226; Table 2). Relatively small ion peaks of penta-acylated 
lipid A appeared at m/z 1671.2 and 1803.2 (Fig. 1A and Table 2), likely due to incomplete 
depletion of lpxLBc gene transcription under non-permissive conditions. Together, the 
MALDI-TOF mass spectrometry analysis supports the notion that LpxLBc is the late 
acyltransferase responsible for adding the fifth acyl chain to the B. cenocepacia lipid A. 
 
Identification of PagL, a lipase responsible for the hypo-acylated lipid A species in B. 
cenocepacia 
Irrespective of the presence or absence of the LpxLBc mediated secondary acyl chain, the 
tetra-acylated and tri-acylated forms of B. cenocepacia K56-2 lipid A under permissive and 
non-permissive conditions, respectively, corresponded to the loss of the primary β-
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hydroxymyristate (3-OH-C14:0) chain, which was previously shown to be at the 3 position of 
the lipid A glucosamine I by negative-ion MALDI-TOF/TOF fragmentation (Sturiale et al., 
2011) (Fig. 4B). This suggests a 3-O-deacylase activity in B. cenocepacia. Scanning the 
genome of B. cenocepacia, we identified BCAL0778, encoding a putative PagL 3-O-
deacylase orthologue, which could be responsible for the removal of the lipid A acyl chain at 
the 3 position; this gene was renamed pagLBc. We constructed a pagLBc deletion mutant and 
examined its lipid A profile by MALDI-TOF mass spectrometry. Fig. 4C shows that loss of 
pagLBc results in penta-acylated lipid A and the concomitant loss of the ion peaks 
corresponding to tetra-acylated molecular species, except for the ion peak at m/z 1444.7 
corresponding to native tetra-acylated, bisphosphorylated glucosamine disaccharide (Table 
2). Despite MALDI-TOF is not quantitative, in relative terms the 1444.7 ion peak is relatively 
small in ΔpagLBc compared to wild type (Fig. 4D), suggesting the possibility of another 3-O-
deacylase activity in B. cenocepacia that is distinct of PagL. 
 
MsbABc complements the growth defect and cell morphology phenotypes caused by LpxLBc 
depletion 
The reduced viability and the morphological cell defects under LpxLBc depletion suggest a 
block in the export of lipid A-core. MsbA is the LPS flippase that transports the lipid A-core 
across the inner membrane (Polissi and Georgopoulos, 1996). In contrast to penta- and 
hexa-acylated lipid A species, tetra-acylated lipid A is considered a poor substrate for MsbA, 
indicating that this protein provides a quality control ensuring the export of appropriate lipid A 
species (Whitfield and Trent, 2014). BCAL2408 is the putative MsbA of B. cenocepacia and 
it was herein renamed as MsbABc. Overexpressing MsbABc in K56-2 (Prha::lpxLBc) restored 
the growth defect associated with the conditional mutant under non-permissive condition 
(Fig. 5A and C). Also, MsbABc overexpressed under the non-permissive condition restored 
cell morphology to normal rod-shape bacterial cells (Fig. 5B). As expected, overexpression 
of MsbA did not affect the lipid A profile. Indeed, the molecular ion peaks detected by 
negative ion MALDI-TOF mass spectrometry in K56-2 (Prha::lpxLBc) overexpressing MsbABc 
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under the non-permissive condition consisted of a mixture of tri- and tetra-acylated lipid A 
(Fig. 5D and Table 2). Therefore, we conclude that MsbABc overexpression increases the 
transport of the tri and tetra-acylated lipid A species across the inner membrane, thus 
alleviating the growth and morphology defects associated to a halt in lipid A-core export 
under LpxLBc depletion.  
 
LpxLBc complements the lipid A defect in E. coli ∆lpxL but not ∆lpxM mutants 
To confirm the functional assignment of BCAL0508 as LpxLBc we performed 
complementation experiments in ∆lpxL and ∆lpxM E. coli strains. For this purpose, lpxLBc 
was cloned in pEXT20 under the control of the β-galactosidase promoter. The recombinant 
plasmid was introduced into the E. coli mutants and protein expression was induced by 0.5 
mM isopropyl β-D-1-thiogalactopyranoside (IPTG). MALDI-TOF mass spectrometry of lipid A 
of the parental E. coli strain W3110 showed a molecular ion peak at m/z 1797.13, which 
corresponds to hexa-acylated bisphosphorylated diglucosamine and it is the most abundant 
ion peak of E. coli lipid A containing four 3-hydroxymyristoyl [C14:0(3-OH)] chains, one 
myristoyl (C14:0) chain, and one lauroyl (C12:0) chain (Fig. 7). Another ion peak appeared 
at m/z 1360.52, which corresponds to tetra-acylated bisphosphorylated diglucosamine 
consisting of one lauroyl and three 3-hydroxymyristoyl chains. These data agree with the 
established structure of the E. coli K-12 lipid A (Raetz and Whitfield, 2002). In E. coli, late 
acyltransferase enzymes LpxL and LpxM add the fifth and sixth acyl chains, respectively, to 
the lipid IVA-Kdo2 precursor (Whitfield and Trent, 2014). LpxL adds a lauroyl (C12:0) chain to 
the 2' position of the diglucosamine while LpxM subsequently adds a myristoyl (C14:0) chain 
onto the 3-hydroxymyristoyl [C14:0(3-OH)] chain at the 3' position of the diglucosamine 
(Clementz et al., 1996, Clementz et al., 1997). The MALDI-TOF mass spectrum of the lipid A 
from E. coli ∆lpxL shows the absence of a lauroyl chain corresponding to ∆m/z= -182 (Fig. 
7), resulting in the appearance of ion peaks at m/z 1615.88 and 1534.14 (penta-acylated), 
m/z 1404.59 and 1324.60 (tetra-acylated) and m/z 1178.29 and 1098.31 (tri-acylated). 
These peaks correspond to bisphosphorylated and monophosphorylated lipid A species, 
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respectively. In contrast, the MALDI-TOF mass spectrum of the lipid A of the complemented 
strain (∆lpxLEc + LpxLBc) shows an additional ion peak at m/z 1825.18 (Fig. 7), which likely 
corresponds to hexa-acylated lipid A containing a myristoyl (C14:0) chain at the 2' position of 
the diglucosamine backbone. This differs from the normally added lauroyl (C12:0) chain in 
the parental E. coli strain W3110. We conclude that although LpxLBc is functional in E. coli it 
has a strict specificity for a myristoyl (C14:0) fatty acid. A similar observation was reported 
for Francisella tularensis (McLendon et al., 2007), suggesting that LpxL orthologues are 
highly specific for the fatty acid substrates in their original backgrounds.  
 The MALDI-TOF mass spectrum of the lipid A from the ∆lpxM mutant lacked a myristoyl 
chain, corresponding to a ∆m/z= -210 (Fig. 7). The ion peaks at m/z 1586.91 and 1507 
(penta-acylated) and m/z 1360.58 and 1280.58 (tetra-acylated) correspond to 
bisphosphorylated and monophosphorylated structures, respectively (Rubin et al., 2014). In 
contrast to the results with ∆lpxL, the complemented strain (∆lpxMEc + LpxLBc) and ∆lpxM 
showed exactly the same lipid A MALDI-TOF profile (Fig. 7). Together, the complementation 
experiments in ∆lpxL and ∆lpxM E. coli mutants indicate LpxLBc functions in a similar manner 
to its E. coli orthologue by adding an acyl chain at the 2' position of the lipid A diglucosamine 
backbone. 
 
Intracellular B. cenocepacia show higher preference towards the formation of penta-acylated 
lipid A that correlates with increased lpxLBc gene transcription  
Lipid A modifications have important implications for host-pathogen interactions (Needham 
and Trent, 2013). B. cenocepacia is an opportunistic pathogen that survives and replicate in 
macrophages (Valvano, 2015). Hence, we investigated whether lipid A modifications occur 
in B. cenocepacia after infection in RAW 264.7 murine macrophages. To increase the 
number of intracellular bacteria and at the same time eliminate more readily the extracellular 
bacteria during the infection experiment, we employed B. cenocepacia mutants lacking O-
antigen (Saldías et al., 2009), which are also sensitive to gentamicin (Hamad et al., 2010). 
These strains were MH1J, a derivative of the naturally O-antigen defective strain J2315 with 
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a mutation in a gentamicin efflux pump, and MH1K ∆BCAL3119-BCAL3131, which has a 
deletion removing most of the O-antigen genes (Hanuszkiewicz et al., 2014). While both 
strains exhibit identical lipid A MALDI-TOF mass spectra as that of K56-2 when grown in LB 
(Fig. 7A), the fragmentation pattern of the lipid A isolated from infected macrophages shows 
a clear shift towards penta-acylated lipid A (Fig. 7C and D, and Table 2). Particularly, the ion 
peak 1933, which corresponds to penta-acylated bisphosphorylated lipid A with 2 Ara4N 
residues (Table 2) and rarely appeared under in vitro growth conditions (LB), was very 
obvious upon macrophage infection. From these experiments, we conclude that intracellular 
environment in macrophages exerts a selective pressure on B. cenocepacia bacterial cells 
to predominantly produce penta-acylated lipid A.  
 We hypothesised that the hyperabundance of penta-acylated lipid A upon macrophage 
infection could reflect either increased expression of lpxLBc or reduced expression of pagLBc. 
Therefore, we compared the expression levels of both genes by qRT-PCR in intracellular 
bacteria with their expression levels in bacterial cells grown in DMEM. The results, which 
were normalized using two standard genes (BCAS0175 and gyrB), indicate 3.3-fold and 3.6-
fold higher lpxLBc and pagLBc expression levels in macrophages compared to the DMEM 
control. These differences, relative to the standard genes, were significant with a p value < 
0.05. We conclude from these data that the higher abundance of penta-acylated lipid A 
species in intracellular bacteria cannot be explained by a simple differential expression of 
lpxLBc and pagLBc and is likely due to a more complex pattern of regulation of LPS synthesis.  
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Discussion 
 
Lipid A is a key component of the bacterial LPS that engages the host innate immune 
system via interactions with the TLR4-MD2 complex. The number and distribution of acyl 
chains in the lipid A, together with the phosphate groups in the diglucosamine backbone, 
influence the interaction of lipid A with the TLR4-MD2 complex (Schromm et al., 2000). 
Generally, this complex is strongly activated by hexa-acylated lipid A and weakly activated 
by hypoacylated lipid A, as the sixth acyl chain bulges from MD2 binding pocket promoting 
dimerization of the TLR4-MD2 complex (Seydel et al., 2000, Park et al., 2009, Maeshima 
and Fernandez, 2013). However, B. cenocepacia LPS can strongly activate human TLR4-
MD2 even though its lipid A possesses a mixture of tetra- and penta-acylated forms (De 
Soyza et al., 2004, Bamford et al., 2007, Hollaus et al., 2015, Silipo et al., 2007, Di Lorenzo 
et al., 2015). 
 In this study, we elucidated the molecular basis of the tetra- and penta-acylation of the B. 
cenocepacia lipid A. We demonstrated that although the lipid A biosynthetic genes are 
conserved (Whitfield and Trent, 2014), there is only a single orthologue of the late 
acyltransferase genes, which corresponds to lpxLBc. From our experiments using MALDI-
TOF mass spectrometry combined with previous structural work by others and us (Hamad et 
al., 2012, Sturiale et al., 2011) we conclude that LpxLBc catalyses the addition of a 
secondary myristoyl chain to the primary acyl chain at the 2' position of the lipid A. This 
modification results in the formation of a penta-acylated lipid A. Complementation 
experiments in E. coli expressing lpxLBc demonstrated this gene encodes an acyltransferase 
with specificity for myristoyl chains. Indeed, LpxLBc adds a myristoyl chain rather than a 
lauroyl chain to the Lipid A of E. coli ∆lpxL but not ∆lpxM. However, the relative ion 
intensities of the fully hexa-acylated species in the complemented strain were lower than 
those of the incomplete acylated forms, which reflect a better functionality of lpxLBc in the 
normal B. cenocepacia background. These experiments confirmed LpxLBc acts as a 
myristoyl transferase.  
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 Failure to delete lpxLBc made us believe this gene is essential for bacterial viability. 
However, using a conditional mutagenesis expression strategy, we showed that depletion of 
LpxLBc expression does not cause loss of viability. In contrast, LpxLBc depleted bacterial cells 
exhibited abnormal cell architecture, strongly suggesting defects in cell division. Further, the 
LpxLBc depletion experiments demonstrated small amounts of tetra- and penta-acylated lipid 
A detectable by negative ion MALD-TOF, suggesting that repression of the rhamnose 
inducible promoter controlling lpxLBc may be only partial and explaining why a clean lpxLBc 
gene deletion could not be obtained. We hypothesized that reduced bacterial growth and the 
cell division defects under non-permissive conditions for full lpxLBc expression were due to 
secondary effects caused by a block in the lipid A export across the membrane. This agrees 
with the notion that tri and tetra-acylated lipid A forms are poor substrates for the MsbA lipid 
A flippase (Zhou et al., 1998). Indeed, overexpression of MsbABc in the Prha::lpxLBc strain 
under the non-permissive condition alleviated the lethal phenotype and restored normal cell 
morphology despite these cells continue to produce tri-and tetra-acylated lipid A. These 
observations are similar to a previous report demonstrating that extra copies of the cloned 
msbA gene from E. coli restored the ability of htrB mutants to grow at 42 °C (non-permissive 
condition) without increasing the extent of lipid A acylation and with a concomitant transport 
of hypoacylated lipid A species to the outer membrane (Zhou et al., 1998). The preferred 
lipid A species for MsbA transport in B. cenocepacia has not been investigated, and it should 
also be considered that the tetra-acylated lipid A species from E. coli and B. cenocepacia 
have different acyl chain distributions. In any case, our results suggest a preference of 
MsbABc for penta-acylated lipid A species, which were absent in bacterial cells depleted from 
LpxLBc. 
 The production of tri- and tetra-acylated forms in B. cenocepacia Prha::lpxLBc  subjected to 
rhamnose depletion was due in both cases to the loss of the primary myristoyl chain at 
position 3 of the diglucosamine backbone. This is the same position to which a myristoyl 
chain is attached in penta-acylated lipid A of other K56-2 strains, but absent in tetra-acylated 
forms (Di Lorenzo et al., 2015, Hamad et al., 2012, Sturiale et al., 2011). Together, these 
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observations suggest the presence of a 3-O-deacylase activity in B. cenocepacia. Lipases 
that remove acyl chains in the lipid A are typically outer membrane proteins, as these 
modifications take place after the flipping of lipid A to the periplasmic side of the membrane. 
In this work, we identified pagL, a gene encoding a predicted outer membrane protein with 
strong similarity to the E. coli PagL. Deletion of this gene resulted in the loss of all tetra-
acylated lipid A species, except for a reduced the ion peak at m/z 1444. This ion peak 
corresponds to tetra-acylated, bisphosphorylated lipid A, and its presence suggests the possibility 
of a second, possibly minor 3-OH deacylase in B. cenocepacia, which is under investigation 
in our laboratory. 
 Lipid A acylation contributes to LPS toxicity. Lipid A can be modified in response to 
environmental stress conditions resulting in increased antimicrobial resistance and evasion 
of recognition by the innate immune system (Llobet et al., 2015, Needham and Trent, 2013). 
We observed that intracellular B. cenocepacia within macrophages produces more penta-
acylated lipid A species suggesting that penta-acylated lipid A is important for survival of B. 
cenocepacia inside macrophages. However, the formation of penta-acylated lipid A could 
not be directly correlated with differential regulation of lpxL and or pagL since both genes 
were more expressed intracellularly than in bacterial culture. We have previously shown that 
intracellular gene expression of B. cenocepacia in macrophages is complex and likely 
involves many gene regulatory cascades (Tolman and Valvano, 2012). The preference of 
penta-acylated lipid A species in macrophages may increase the proinflammatory nature of 
the intracellular infection. This agrees with the suggestion that B. cenocepacia lipid A 
activates TLR4 through the interaction of the fifth acyl chain with TLR4 by the aid of longer 
acyl chains and L-Ara4N residues, which in turn evokes a robust proinflammatory response 
(Di Lorenzo et al., 2015). A similar situation was also observed in Haemophilus influenzae 
(Swords et al., 2002) and F. tularensis (McLendon et al., 2007) in which the expression of 
the lpxL gene increases during infection of human airway epithelial cells and macrophages, 
respectively compared to in vitro growth conditions. Pseudomonas aeruginosa strains can 
also regulate the degree of lipid A acylation in response to environmental conditions as they 
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normally possess penta-acylated lipid A. However, they can form hexa-acylated lipid A 
during infection in cystic fibrosis patients eliciting a more robust inflammatory response and 
possibly increasing the level of membrane packing and the bacterial resistance to 
antimicrobial peptides (Hajjar et al., 2002).  
 In conclusion, this work reveals two critical enzymes that control the number of acyl 
chains of lipid A in B. cenocepacia. Elucidation of the lipid A biosynthesis and its remodelling 
in this group of bacteria could provide novel insights in the pathogenesis of B. cenocepacia 
and other Burkholderia species. Future studies are required to address the regulatory 
mechanism of lipid A synthesis and modifications in B. cenocepacia under various 
conditions including the intracellular environment. 
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Experimental Procedures 
 
Strains and growth conditions 
Bacterial strains and plasmids used in this study are described in Table 1. Bacteria were 
cultured in Luria-Broth (LB) medium or M9 medium at 37°C. Unless indicated otherwise 
antibiotics used (final concentrations) were: trimethoprim (50 µg ml−1 for E. coli and 100 µg 
ml−1 for B. cenocepacia), tetracycline (30 µg ml−1 for E. coli and 100 µg ml−1 for B. 
cenocepacia), kanamycin (40 µg ml−1 to maintain the helper plasmid pRK2013 in E. coli), 
and gentamicin (50 µg ml−1 to counter select against the E. coli donor and helper strains in 
triparental matings).  
 
Recombinant DNA techniques 
Restriction enzymes were obtained from New England Bio labs (NEB). T4 DNA ligase and 
alkaline phosphatase were obtained from Roche Diagnostics. DNA amplifications by PCR 
were done with Taq or HotStar HiFidelity DNA polymerases (Qiagen), and DNA sequencing 
was performed at GATC Biotech (London, UK). Conjugations were performed by triparental 
mating (Craig et al., 1989) with the pRK2013 helper plasmid (Figurski and Helinski, 1979). 
Deletion mutagenesis was performed as previously described (Flannagan et al., 2008, 
Aubert et al., 2014). The mutagenic plasmid pMH481, for the construction of the pagL 
(BCAL0788) deletion mutant, carried upstream and downstream sequences of pagL, which 
were obtained by PCR amplification with primer pairs 4740/4741 and 4728/4729 (Table 2). 
These amplicons were digested with SspI/ClaI and ClaI/XbaI, respectively, and triple-ligated 
into pGPI-SceI-2 (Hamad et al., 2012) between SspI and XbaI sites. 
 
Conditional mutagenesis 
Conditional mutants were constructed as described previously (Mohamed and Valvano, 
2014, Ortega et al., 2007). A 300-bp fragment of the upstream region of the lpxLBc gene 
(BCAL0508) was amplified and cloned into pSC200 behind the plasmid-borne rhamnose 
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promoter. Transformation was carried out in E. coli GT115 competent cells by the calcium 
chloride method (Cohen et al., 1972). Transformants were selected on LB agar plates 
containing 50 μg trimethoprim ml-1. Plasmids were mobilized into B. cenocepacia K56-2, and 
exconjugants were isolated on LB agar plates supplemented with 100 μg trimethoprim ml-1, 
200 μg ampicillin ml-1, 20 μg polymyxin B ml-1 and 0.2% rhamnose. This experiment resulted 
in the isolation of the conditional mutant strain YFM51 (Prha::lpxLBc; Table1).  
 
Complementation experiments  
We constructed the plasmid pYEM66 (pEXT20-lpxLBc), in which lpxL (BCAL0508) gene 
expression was placed under the control of the lac promoter using primers Q868 and Q867 
(Table S1). The plasmid was introduced into E. coli ΔlpxL and ΔlpxM mutants (Table 1) by 
electroporation and transformants were selected on LB agar plates containing 50 μg 
kanamycin ml-1 and 100 μg ampicillin ml-1. A plasmid constitutively expressing MsbABc 
(pYM40) was constructed by amplifying the msbA gene (BCAL2408) with primers Q714 and 
Q715 (Table S1). Amplicons were digested with NdeI-XbaI and cloned into a similarly 
digested pDA12, resulting in pDA12-lpxLBc. This plasmid was introduced into the conditional 
mutant strain YFM51 by triparental mating and exconjugants selected on LB agar plates 
containing 100 μg tetracycline ml-1, 100 μg trimethoprim ml-1, 200 μg ampicillin ml-1, 20 μg 
polymyxin B ml-1 and 0.2% rhamnose.  
 
Rhamnose depletion experiment 
Conditional viability of mutants was assessed as described previously (Mohamed and 
Valvano, 2014, Ortega et al., 2007). Conditional mutants were cultured in M9 minimal 
medium supplemented with 0.5% yeast extract, 100 μg trimethoprim ml-1 and 0.2% 
rhamnose and were left to grow overnight at 37°C. Bacterial pellets were washed three 
times with phosphate-buffered saline (PBS) and OD600 was adjusted to 1. Ten μl of 10-1 to 
10-6 dilutions were inoculated onto LB agar plates supplemented with either 0.2% glucose or 
0.2% rhamnose and incubated at 37°C for 24 h. The same procedure was used to 
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complement the loss of viability of YFM51 by expressing MsbABc. The essentiality of lpxMBc 
was further demonstrated by monitoring growth in liquid medium in a rhamnose depletion 
assay in which washed, rhamnose-depleted cells were diluted in M9 medium supplemented 
with 0.5% yeast extract and 0.2% glucose and aliquoted to 100-well honeycomb plate and 
monitored for growth for 20 h in a Bioscreen C (Oy Growth Curves Ab, Finland). Cultures 
were first diluted to OD600 of 0.1, allowed to grow for 4 h then further diluted to an OD600 of 
0.005 in fresh M9 medium and grown as previously described (Mohamed and Valvano, 
2014). 
 
Microscopy 
Samples of depleted cultures grown in the absence of rhamnose were taken at 2, 6, 16, and 
20 h, placed on 0.8% agarose slides, covered with a coverslip and examined by phase-
contrast and differential interference contrast microscopy using a Zeiss Axioimager 2. 
Bacteria were also stained with the LIVE/DEAD® BacLight™ Bacterial Viability Kit and 
images recorded by fluorescence microscopy. Images were processed by ImageJ on the Fiji 
platform (Schindelin et al., 2012). Samples depleted for at lest 12 h were also examined by 
transmission electron microscopy after fixing with 2.5% glutaraldehyde and staining with 2% 
uranyl acetate and lead citrate, as previously described (Schmerk and Valvano, 2013). Grids 
were visualized with a Philips 410 transmission electron microscope at 60 kV in the 
Transmission Electron Microscopy Facility, Department of Microbiology and Immunology, 
University of Western Ontario.  
 
Lipid A Extraction and Mass Spectrometry 
Lipid A modifications were investigated by mass spectrometry (MS) using Matrix-assisted 
laser desorption/ionization time of flight (MALDI-TOF). Cells were grown overnight in LB 
medium or for 16 h in M9 medium with 0.5% of yeast extract in the case of depletion 
experiments. For strains containing the Prha::LpxLBc insertion in the genome the medium was 
also supplemented with 100 μg trimethoprim ml-1 and either 0.2 % rhamnose or 0.2 % 
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glucose, as appropriate. Cultures were centrifuged (10,000 xg), washed twice with 
phosphate buffer (10 mM Na2HPO4, 1.7 mM KH2PO4) and freeze-dried. Lipid A was 
extracted from lyophilized cells and de-salted as previously described (El Hamidi et al., 
2005). Ten mg of the lyophilized bacterial cells were resuspended in 400 μl of a mixture of 
isobutyric acid:1 M ammonium hydroxide (5:3, v/v) and kept on a heat block for 2 h at 100°C 
with vortexing every 15 min. After centrifugation at 2000 xg for 15 min the supernatant was 
mixed with an equal volume of water and lyophilized overnight. Samples were then washed 
with methanol and lipid A was solubilized in 80 μl of chloroform:methanol:water (3:1.5:0.25, 
v/v). The lipid A suspension was desalted by adding a few grains of Dowex 50W-X8 (H+) ion-
exchange resin. A two-microliter aliquot of lipid A suspension was loaded on polished steel 
target, air dried and covered by 1 μl of 2,5-dihydroxybenzoic acid matrix (Sigma) dissolved 
in 0.1 M citric acid aqueous solution and allowed to air dry. The target was inserted in a 
Bruker Autoflex MALDI-TOF spectrometer. Data acquisition and analysis were performed 
using the Flex Analysis software.  
 
Infection of murine RAW 264.7 macrophages 
Murine RAW 264.7 cells were grown in Dulbecco's modified Eagle medium (DMEM) medium 
(Gibco) supplemented with 10% foetal bovine serum (FBS; Gibco), L-glutamine (2 mM; 
Gibco) and HEPES (10 mM; Gibco) at 37°C in a 95% humidified atmosphere with 5% CO2. 
For extraction of B. cenocepacia RNA, T75 Nunc flasks each containing a monolayer of 
macrophages (~107 cells) were infected with bacteria at a multiplicity of infection (MOI) of 
200:1. To synchronize the infection the plates were centrifuged at 180 xg for 5min, and this 
was considered as time 0 h. After 1 h postinfection, extracellular bacteria were killed with 
100 mg ml-1 gentamicin. After another 1 h, the DMEM media was replaced with fresh 
medium containing 10 μg ml-1 gentamicin. Incubation was continued for 6-8 h before 
additional processing of the samples for lipid A analyses or mRNA extraction. 
 
Lipid A extraction from intracellular bacteria 
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Infected macrophages from 2 flasks, as described above, were pooled at 8 h postinfection, 
washed with PBS and resuspended in 800 µl of PBS. Two ml of methanol and 1 ml of 
chloroform were added and the suspension was mixed by vortexing and incubated for 30 
min at room temperature with occasional vortexing. Pellets were then collected by 
centrifugation at 2000 xg for 15 min and resuspended in 4 ml of single-phase Bligh/Dyer 
system (chloroform:methanol:water, ratio 1:2:0.8 v/v respectively). Pellets were collected 
and resuspended in 400 μl of a mixture of isobutyric acid: 1 M ammonium hydroxide (5:3, 
v/v) and then processed as described above. 
 
RNA extraction from intracellular bacteria and quantitative or real-time RT-PCR (qRT-PCR) 
At 8 h postinfection, macrophages were lysed on ice for 30 min in 0.1% SDS, 1% acidic 
phenol, 19% ethanol in water as previously described (Eriksson et al., 2003). Cells were 
then pooled from 6 flasks and pellets were collected by centrifugation and washed with a 
solution containing 0.1% acidic phenol, 19% ethanol in water, and then resuspended in 1 ml 
of tri-reagent (Ambion). RNA was prepared by traditional phenol-chloroform extraction and 
DNA was removed by treatment with DNAse (Roche) for 30 min at 37°C. Control RNA from 
in vitro bacteria was acquired by growing MH1K statically at 37°C in complete DMEM 
medium under 5% CO2 to mimic conditions used for the infection experiments. RNA was 
then isolated as described above.  
 cDNA was obtained from 1 μg total RNA by using a commercial Moloney murine 
leukaemia virus (M-MLV) reverse transcriptase (Invitrogen, UK) with random primers. Real-
time PCR (RT-PCR) analyses were performed with a Mx3005p qPCR system (Agilent 
Technologies, UK). Hundred nanograms of cDNA were used as the template in a 20-μl 
reaction mixture containing KapaSYBR Fast qPCR mix (Kapa Biosystems) and primer mix. 
BCAS0175 and gyrB genes were ampliﬁed as housekeeping genes. The primers used are 
listed in Table S1. The thermocycling protocol was as follows: 95°C for 3 min for hot-start 
polymerase activation, followed by 45 cycles of denaturation at 95°C for 15 s and annealing 
at 60°C for 30 s. SYBR green dye ﬂuorescence was measured at 521 nm during the 
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annealing phase. Fold changes in gene expression were calculated using the Livak method 
(∆∆ CT) (Livak and Schmittgen, 2001) with normalization to BCAS0175 and gyrB genes 
(Peeters et al., 2010).  
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Table 1. Bacterial strains and plasmids  
Strain or 
plasmid 
Characteristicsa Source or 
reference 
 
E. coli K-12 
DH5α 
 
 
F- ɸ80 lacZ∆M15 endA1 recA1 hsdR17(r-Km+K) 
supE44 thi-1∆gyrA96 (∆lacZYA-argF)U169 
relA1F- mcrA ∆(mrr-hsdRMS-mcrBC)  
 
 
Invitrogen 
GT115 ɸ80lacZ∆M15 ∆lacX74 recA1 rpsL endA1 
∆dcm uidA(∆MluI)::pir-116 ∆sbcC-sbcD 
Lab stock 
W3110 F- I- rph-1 INV (rrnD-rrnE)1 rph-1 Lab stock 
∆lpxL W3110, ∆lpxL; KnR Lab stock 
BN2 W3110, ∆lpxM; KnR  (Needham et al., 
2013) 
   
 
B. cenocepacia 
K56-2 
 
 
Clinical isolate, ET12 clone related to J2315  
 
 
BCRRCb 
MH1K K56-2; ∆amrABC (BCAL1674-1676); GmS, 
KnS 
(Hamad et al., 
2010) 
MH1J J2315; cystic fibrosis clinical isolate; ∆amrABC 
(BCAL1674-1676); GmS, KnS  
(Hamad et al., 
2010) 
MH76 K56-2; ∆pagL (BCAL0788) This study 
MV4179 MH1K; ∆O-antigen cluster (BCAL3119-
BCAL3131) 
(Hanuszkiewicz 
et al., 2014) 
YFM51 K56-2; Prha::lpxLBc (BCAL0508); Tp
R This study 
YFM52 K56-2; Prha::lpxLBc (BCAL0508); Tp
R  
pDA12-6xHis-MsbABc;  
This study 
YFM53 K56-2; Prha::lpxLBc (BCAL0508); Tp
R 
pDA12 
This study 
 
Plasmids 
 
 
 
 
pDA12 Cloning vector, oripBBR1, TetR, mob+, Pdhfr (Aubert et al., 
2008) 
pDAI-SceI-SacB 
 
oripBBR1, TetR, Pdhfr, mob+, expressing ISce-I, 
also expresses negative selection marker 
SacB 
(Hamad et al., 
2010) 
pGPISce-I oriR6K, mob+, ΩTpR , including an ISce-I 
restriction site 
(Flannagan et 
al., 2008) 
pGPISce-I-2 pGPISce-I with additional unique cloning sites (Hamad et al., 
2012).  
pMH481 pGPISce-I; pagL deletion plasmid This study 
pRK2013 oricolE1, RK2 derivative, KnR, mob+, tra+  (Figurski and 
Helinski, 1979) 
pSC200 Cloning vector, oripBBR1 rhaR, rhaS, PrhaB, 
TpR 
(Cardona and 
Valvano, 2005) 
pXO53 pSC200-lpxLBc This study 
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pYM40 msbABc (BCAL2408) cloned in pDA12 with a 
C-terminal 6xHis tag, TetR 
This study 
pYM66 lpxLBc (BCAL0508) cloned in pEXT20, AmpR This study 
 
a KnR, kanamycin resistance; GmS, gentamicin sensitive; KnS, kanamycin sensitive; TpR, 
trimethoprim resistance, TetR, tetracycline resistance, AmpR, ampicillin resistance.  
bBurkholderia cepacia Research and Referral Repository for Canadian Cystic Fibrosis 
Clinics. 
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Table 2. List of observed m/z ion peaks by MALDI-TOF analysis of LPS samples from 
B. cenocepacia K56-2 parental and mutant strains used in this study  
 
Observed ion Assignment 
(m/z) 
_________________________________________________________________________ 
1154.6   Tri-acyl [2 GlcN + 14:0(3-OH) + 2 16:0(3-OH)], 1 P 
1234.6   Tri-acyl [2 GlcN + 14:0(3-OH) + 2 16:0(3-OH)], 2 P 
1285.7   Tri-acyl [2 GlcN + 14:0(3-OH) + 2 16:0(3-OH)], 1 Ara4N, 1P 
1364.7   Tetra-acyl [2 GlcN + 14:0(3'-OH) + 2 16:0(3-OH) + 14:0], 1 P 
1366.7   Tri-acyl [2 GlcN + 14:0(3-OH) + 2 16:0(3-OH)], 1 Ara4N, 2P 
1444.7   Tetra-acyl [2 GlcN + 14:0(3'-OH) + 2 16:0(3-OH) + 14:0], 2 P 
1460.9   Tetra-acyl [2 GlcN + 2 14:0(3-OH) + 2 16:0(3-OH)], 2 P 
1495.9   Tetra-acyl [2 GlcN + 14:0(3'-OH) + 2 16:0(3-OH) + 14:0], 1 Ara4N, 1P 
1497.1   Tri-acyl [2 GlcN + 14:0(3-OH) + 2 16:0(3-OH)], 2 Ara4N, 2P 
1576.8   Tetra-acyl [2 GlcN + 14:0(3'-OH) + 2 16:0(3-OH) + 14:0], 1 Ara4N, 2P 
1593.1   Tetra-acyl [2 GlcN + 2 14:0(3-OH) + 2 16:0(3-OH)], 1 Ara4N, 2 P 
1671    Penta-acyl [2 GlcN + 14:0(3'-OH) + 2 16:0(3-OH) + 14:0(3-OH) + 14:0], 2 P 
1707.9   Tetra-acyl [2 GlcN + 14:0(3'-OH) + 2 16:0(3-OH) + 14:0], 2 Ara4N, 2 P 
1803.1   Penta-acyl [2 GlcN + 14:0(3'-OH) + 2 16:0(3-OH) + 14:0(3-OH) + 14:0], 1 Ara4N, 2P 
1933.8   Penta-acyl [2 GlcN + 14:0(3'-OH) + 2 16:0(3-OH) + 14:0(3-OH) + 14:0], 2 Ara4N, 2P 
_________________________________________________________________________________ 
Spectra corresponding to the ion peaks are shown in Fig. 4. The assignments were based on 
previously published data (Hamad et al., 2012, Sturiale et al., 2011). GlcN, glucosamine; P, 
phosphate; Ara4N, 4-L-amino-4-deoxyarabinose. 
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Figure Legends 
 
Figure 1. Lipid A biosynthesis in B. cenocepacia. Lipid A biosynthetic enzymes in B. 
cenocepacia were identified using blast analysis with respect to their E. coli orthologues. 
The BCAL numbers correspond to the gene annotations of B. cenocepacia J2315, denoting 
genes in the larger chromosome. 
A. The first 6 steps of the Raetz pathway, leading to the formation of lipid IVA, are predicted 
to be identical as those in E. coli, with the exception that the two amide-linked acyl chains 
are 16:0(3-OH) residues (Silipo et al., 2005). 
B. Two Kdo residues are incorporated by the enzyme WaaA; the distal Kdo is modified into 
D-glycero-D-talo-oct-2-ulosonic acid (Ko) by KdoO (Chung and Raetz, 2011, Chung et al., 
2014). The doted circles indicate the Kdo groups modified by the Kdo hydroxylase; it is not 
clear if this step occurs before or after the addition of the 14:0(3-OH) acyl chain by LpxL. 
The incorporation of the secondary 14:0(3-OH) acyl chain (in grey) to the primary acyl chain 
at position 2', mediated by LpxL, is also indicated (dotted square). 
  
Figure 2. LpxLBc is required for the viability of B. cenocepacia. 
A. Conditional lethal phenotype of strain K56-2 carrying the chromosomal Prha::lpxLBc 
transcriptional fusion that places the lpxL gene under the control of a rhamnose-inducible 
promoter. Bacterial culture dilutions were spotted on LB agar plates supplemented with 0.2% 
rhamnose (permissive condition) or 0.2% glucose (non-permissive condition). 
B. Rhamnose depletion experiment in liquid medium of strain K56-2 carrying the Prha::lpxLBc 
transcriptional fusion. Growth was monitored every hour using a Bioscreen C instrument. 
Cultures were grown in M9 minimal medium with 0.2% rhamnose for 4 h (arrow) at which 
point bacteria were sedimented, washed with fresh medium with no rhamnose, and divided 
into two cultures with and without rhamnose. Solid black circles (permissive condition with 
0.2% rhamnose); Open circles (non-permissive condition with 0.2% glucose). The figure is 
representative of three independent biological repeats with similar results.   
C. The morphology of K56-2 Prha::lpxL bacteria grown under permissive (0.2% rhamnose) 
and non-permissive (0.2% glucose) conditions was examined by differential interference 
contrast (DIC) using oil-immersion objective lens in a Zeiss Axioscope II microscope 
(Magnification: 1,000 X). Bacteria were also stained with the LIVE/DEAD® BacLight™ 
Bacterial Viability Kit. Images recorded in the green fluorescent channel, which were stained 
with Syto9 are shown. Insets in each panel show additional detail, especially the 
fluorescently stained disorganized nucleoids (arrowheads) and the constrictions indicating 
defects in bacterial cell division (arrows).   
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Figure 3. Ultrastructure of the K56-2(Prha::lpxL) bacterial cells. Bacteria were examined 
by transmission electron microscopy after fixation with 2.5% glutaraldehyde and staining 
with 2% uranyl acetate and lead citrate. Bar, 0.5 μm 
A. Bacteria grown in 0.2% rhamnose (permissive condition). 
B-F. Bacteria initially grown in rhamnose were depleted for 12 h in 0.2% glucose. Empty 
sacculi (black arrows) and accumulation of membranous structures (white arrows) are 
shown. 
Figure 4. Characterization of the lipid A in B. cenocepacia strain K56-2 carrying the 
Prha::lpxL promoter fusion under permissive and non-permissive conditions and the 
isogenic ΔpagL mutant.  
A. Negative ion MALDI-TOF mass spectra of lipid A isolated from K56-2 Prha::lpxL grown 
under permissive (rhamnose) and non-permissive (glucose) conditions. Ara4N, 4-L-amino-4-
deoxyarabinose.  
B. The deduced bisphosphorylated lipid A structures produced by the K56-2 Prha::lpxL strain 
under permissive (rhamnose) and non-permissive (glucose) conditions are shown as a 
reference. The structures with one phosphate and with one or two Ara4N molecules are not 
represented. The LpxL-mediated acyl chain addition is shown in grey (dotted rectangles).  
The 3' and 3 positions of the lipid A where the β-hydroxymyristate (3-OH-C14:0) is attached 
by LpxA (see Fig. 1) and removed from the 3-position by the PagL deacylase (see panels C 
and D) are indicated.   
C. Negative ion MALDI-TOF mass spectra of lipid A isolated from K56-2 and the ΔpagL 
mutant. Ara4N, 4-L-amino-4-deoxyarabinose.  
D. Deduced bisphosphorylated lipid A structures produced by K56-2 and the ΔpagL mutant 
shown for reference. Alternative structures are not represented. The LpxL-mediated acyl 
chain addition is shown in grey. The 3' and 3 positions of the lipid A where the β-
hydroxymyristate (3-OH-C14:0) is attached by LpxA (see Fig. 1) and removed from the 3-
position by the PagL deacylase are indicated.  
 
Figure 5. Overexpression of MsbA rescues growth of K56-2 Prha::lpxLBc under the non-
permissive condition. 
A. Growth of the conditional mutant K56-2 Prha::lpxLBc strain with vector control (pDA12) (left 
panel) and with pDA12-msbABc (right panel). Bacteria were grown overnight with 0.2% 
rhamnose, serially diluted and plated on LB supplemented with 0.2% glucose (non-
permissive condition). 
	 35	
B. Phase contrast microscopy of K56-2 Prha::lpxLBc bacterial cells containing the pDA12 
vector control (left panel) and K56-2 Prha::lpxLBc cells overexpressing MsbABc (right panel) 
under the non-permissive condition.  
C. Depletion experiments using K56-2 Prha::lpxLBc carrying either pDA12 (vector control) or 
pDA12-msbABc. The figure is representative of three independent biological repeats with 
similar results.  
D. Negative ion MALDI-TOF mass spectrum of lipid A extracted from K56-2 Prha::lpxLBc + 
MsbABc under the non-permissive condition. 
 
Figure 6. Complementation of E. coli ∆lpxL by B. cenocepacia LpxLBc. Negative ion 
MALDI-TOF mass spectra of lipid A isolated from the parental E. coli K12 strain W3110 and 
the W3110 ∆lpxLEc and ∆lpxMEc mutans alone or complemented by the introduction of a 
plasmid encoding the B. cenocepacia LpxLBc protein. The insert indicates the structural 
representation of the lipid A structure deduced from the MALDI-TOF mass spectrum in the 
∆lpxLEc mutant complemented with LpxLBc, which shows hexa-acylated lipid A containing a 
myristoyl (C14:0) group (dotted-line rectangle) incorporated by LpxLBc. The myristoyl group 
incorporated by the E. coli LpxM is also indicated. 
 
Figure 7. Characterization of B. cenocepacia lipid A produced by intracellular bacteria 
within macrophages. Negative ion MALDI-TOF mass spectra of lipid A purified from MH1J 
and MH1K derivatives of strains J2315 and K56-2, respectively. These derivatives contain a 
deletion of an antibiotic efflux pump that allows monitoring bacterial intracellular survival by 
eliminating extracellular bacteria upon incubation with kanamycin (Hamad et al., 2010). 
Intracellular bacteria were collected 8 h post-infection and processed to obtain lipid A for 
analysis as described in Experimental Procedures 
A. Control lipid A from MH1J grown in LB. 
B. Mass spectrum profile of non-infected RAW264.7 murine macrophages as a negative 
control. 
C. Lipid A from intracellular MH1J in RAW264.7 murine macrophages 
D. Lipid A from intracellular MH1K ∆BCAL3119-3131 (∆O-antigen) in RAW264.7 murine 
macrophages. The loss of O-antigen facilitates B. cenocepacia intracellular infection in 
macrophages (Saldías et al., 2009). 
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